Obermeyer Wealth Partners acquired a new stake in shares of McKesson Corporation (NYSE:MCK - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 29,936 shares of the company's stock, valued at approximately $25,560,000. McKesson comprises 1.0% of Obermeyer Wealth Partners' holdings, making the stock its 25th biggest holding.
A number of other large investors have also added to or reduced their stakes in MCK. BlackRock Inc. bought a new position in shares of McKesson during the second quarter valued at $8,156,743,000. Bank of America Corp DE raised its position in shares of McKesson by 2.4% in the 1st quarter. Bank of America Corp DE now owns 1,538,726 shares of the company's stock worth $1,331,552,000 after purchasing an additional 35,916 shares during the last quarter. Swedbank AB raised its position in shares of McKesson by 13.5% in the 1st quarter. Swedbank AB now owns 1,005,610 shares of the company's stock worth $870,215,000 after purchasing an additional 119,327 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of McKesson by 3.3% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 922,573 shares of the company's stock worth $697,096,000 after purchasing an additional 29,747 shares during the last quarter. Finally, Legal & General Group Plc bought a new position in McKesson in the 2nd quarter worth about $656,566,000. Hedge funds and other institutional investors own 85.07% of the company's stock.
McKesson Price Performance
McKesson stock opened at $1,014.79 on Thursday. McKesson Corporation has a one year low of $723.68 and a one year high of $1,030.27. The stock has a market capitalization of $118.31 billion, a PE ratio of 27.16, a price-to-earnings-growth ratio of 2.05 and a beta of 0.30. The business's fifty day moving average is $905.65 and its 200 day moving average is $840.38.
McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, topping the consensus estimate of $9.56 by $0.37. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The company had revenue of $105.38 billion during the quarter, compared to the consensus estimate of $103.88 billion. During the same period last year, the company earned $8.26 EPS. McKesson's revenue for the quarter was up 7.7% on a year-over-year basis. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, sell-side analysts expect that McKesson Corporation will post 44.71 EPS for the current fiscal year.
McKesson Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be paid a $0.94 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson's payout ratio is currently 10.06%.
Insider Transactions at McKesson
In other news, Director Bradley Lerman sold 301 shares of McKesson stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $892.33, for a total value of $268,591.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Francisco Fraga sold 800 shares of the business's stock in a transaction that occurred on Thursday, October 15th. The shares were sold at an average price of $995.80, for a total transaction of $796,640.00. Following the transaction, the executive vice president directly owned 5,423 shares of the company's stock, valued at $5,400,223.40. The trade was a 12.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,212 shares of company stock worth $1,164,182 over the last three months. 0.06% of the stock is currently owned by company insiders.
Analyst Ratings Changes
MCK has been the topic of several recent analyst reports. Robert W. Baird set a $1,015.00 price objective on shares of McKesson in a research report on Thursday, August 6th. TD Cowen raised their price objective on shares of McKesson from $989.00 to $1,006.00 and gave the company a "buy" rating in a research note on Thursday, August 6th. Leerink Partners increased their price target on shares of McKesson from $1,030.00 to $1,070.00 and gave the company an "outperform" rating in a report on Wednesday, October 7th. Mizuho raised their price target on shares of McKesson from $905.00 to $1,020.00 and gave the company a "neutral" rating in a research report on Tuesday. Finally, Wells Fargo & Company boosted their price objective on shares of McKesson from $812.00 to $933.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 11th. Fifteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $997.12.
View Our Latest Stock Report on MCK
Key Headlines Impacting McKesson
Here are the key news stories impacting McKesson this week:
- Positive Sentiment: Analyst price-target increases supported the long-term outlook. UBS raised its target to $1,200, while Mizuho lifted its target to $1,020 from $905, although Mizuho maintained a neutral rating. The analyst actions followed McKesson’s recent strength and helped the stock reach a new one-year high. UBS raises target for McKesson
- Positive Sentiment: McKesson declared its regular quarterly dividend. The company will pay $0.94 per share on January 4, 2027, to shareholders of record on December 1. The dividend provides continuity for income-focused investors, though the annualized yield is modest at approximately 0.4%. McKesson declares quarterly dividend
- Neutral Sentiment: Investor attention remains elevated. McKesson was among the more-trending stocks on Zacks, but the article primarily reviews existing fundamentals rather than introducing a new catalyst. Its latest reported quarter showed earnings and revenue above estimates, with revenue up 7.7% year over year and fiscal 2027 EPS guidance of $44.20–$45.00. Is Trending Stock McKesson a Buy Now?
- Negative Sentiment: An executive sale may have added modest selling pressure. EVP Francisco Fraga sold 800 shares worth approximately $796,640. However, the transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, reducing its significance as a discretionary bearish signal. McKesson executive stock sale
About McKesson
(
Free Report)
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.
McKesson's principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.
Featured Articles
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider McKesson, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.
While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.